Commerce Bank Neurocrine Biosciences Inc Transaction History

Commerce Bank

$16.1 Billion
Q3 2024

A detailed history of Commerce Bank transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Commerce Bank holds 4,199 shares of NBIX stock, worth $527,016. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,199

Previous 4,091 2.64%

Holding current value

$527,016

Previous $563,000 14.21%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$114.58 - $153.15 $12,374 - $16,540	108 Added 2.64%	4,199 $483,000
Q2 2024 Aug 12, 2024	BUY	$130.86 - $143.19 $535,348 - $585,790	4,091 New	4,091 $563,000
Q2 2022 Aug 12, 2022	SELL	$75.79 - $100.07 $164,161 - $216,751	-2,166 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$72.45 - $94.81 $156,926 - $205,358	2,166 New	2,166 $203,000
Q3 2021 Nov 09, 2021	SELL	$86.18 - $99.03 $532,247 - $611,609	-6,176 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$89.43 - $102.27 $1,073 - $1,227	-12 Reduced 0.19%	6,176 $601,000
Q1 2021 May 05, 2021	BUY	$87.57 - $119.4 $24,519 - $33,432	280 Added 4.74%	6,188 $602,000
Q4 2020 Feb 09, 2021	BUY	$86.91 - $108.33 $179,469 - $223,701	2,065 Added 53.73%	5,908 $567,000
Q3 2020 Nov 06, 2020	BUY	$96.16 - $135.15 $6,058 - $8,514	63 Added 1.67%	3,843 $370,000
Q2 2020 Aug 07, 2020	SELL	$85.09 - $130.36 $1,021 - $1,564	-12 Reduced 0.32%	3,780 $461,000
Q1 2020 May 08, 2020	BUY	$75.11 - $113.76 $88,404 - $133,895	1,177 Added 45.01%	3,792 $328,000
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $226,982 - $310,060	2,615 New	2,615 $281,000

Others Institutions Holding NBIX

# of Institutions

629

Shares Held

94.2M

Call Options Held

692K

Put Options Held

406K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.

Account